CLM-SAP 19: 2018 Guideline on the Management of Blood Cholesterol

Cardiology
Curriculum:
N/A
Credits:
5.5 AMA PRA Category 1 Credit(s)™ 5.4 ANCC Contact Hours 5.5 ACPE 5.5 CDR 2.3 Pharmacology
Launch Date:
October 25, 2019
Expiration Date:
October 25, 2022

Primary Audience:

Physicians, Physician Assistants, Pharmacists, Dietitians, Nurses

Relevant Terms:

2018 Guideline on the Management of Blood Cholesterol

1. Analyze the 2018 blood cholesterol guideline. 
2. Evaluate representative clinical cases for the management of dyslipidemia.
3. Create evidence-based treatment plans based on recommendations from the 2018 cholesterol guideline. 
4. Recognize differences in lipid management recommendations for special populations
5. Explain recommendations for managing dyslipidemia relative to specific disease states
6. Describe the principles of lipid management for primary and seconary prevention of ASCVD
7. Recommend effective diet and lifestyle strategies for dyslipidemia management
8. Describe statin-associated side effects and identify guideline recommended management strategies

PROGRAM OVERVIEW
In 2018, the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines released an updated guideline on the management of blood cholesterol.  This guideline, which is based on systematic methods to evaluate and classify evidence, provides a foundation for the delivery of quality cardiovascular care.

This Complex Lipid Management Self-Assessment Program (CLM-SAP) reviews this important guideline in order to reduce gaps in implementation of evidence-based therapies.

RELEASE DATE: October 25, 2019

EXPIRATION DATE: October 25, 2022

ACTIVITY FORMAT: Enduring Internet Activity

CRITERIA FOR SUCESS

Before beginning this activity, participants are required to read following document:

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

To receive credit for this enduring program, participants must answer each question, review the ensuing critiques and evaluate the activity. To receive credit, you must obtain a 70% or greater total score on your Performance Score Report. A statement of credit will be available upon completion of an online evaluation form. If you have questions about this CME/ CE activity, please contact the NLA at cme@lipid.org.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

CREDIT DESIGNATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this enduring internet activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 5.50 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacists
 Universal Activity Number - JA0007192-0000-19-051-H01-P (Application)

This Activity has been approved for 5.50 contact hour(s) (.550 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 5.4 contact hours

For the advanced practice nurse, this activity has 2.3 contact hours of pharmacotherapy content.

COMMERCIAL SUPPORT
There is no commercial support for this activity. 

PROGRAM FACULTY

Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, FNLA
EDITOR-IN-CHIEF
Professor and Vice Chair
Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado
Anschutz Medical Campus
Aurora, CO

Lynne T. Braun, PhD, CNP, CLS, FAHA, FPCNA, FAANP, FNLA, FAAN
Professor of Nursing and Medicine, Rush University
Nurse Practitioner, Rush Heart Center for Women
Chicago, IL

Carl E. Orringer, MD, FNLA, FACC*
Associate Professor of Clinical Medicine
Director of Preventive Cardiovascular Medicine
University of Miami Miller School of Medicine
Miami, FL

*Denotes Diplomate, American Board of Clinical Lipidology.

FACULTY DISCLOSURES

NAME

RELATIONSHIP

COMPANY

Joseph J. Saseen

N/A

Nothing to disclose

Lynne T. Braun

N/A

Nothing to disclose

Carl E. Orringer

N/A

Nothing to disclose

NLA Staff/Planners

N/A

Nothing to disclose

B Alan Bottenberg- ICE Committee Reviewer

N/A

Nothing to disclose

Khalid Hasan Sheikh - ICE Committee Reviewer

Speakers Bureau

Amarin Pharmaceuticals, Amgen Pharmaceuticals

Sean D. Stewart- ICE Committee Reviewer

N/A

Nothing to disclose

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCT
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME. 

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

COURSE VIEWING REQUIREMENTS

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above